Please provide your email address to receive an email when new articles are posted on . NEW YORK — Valsalva retinopathy usually has a favorable visual prognosis, according to a study. Most eyes ...

Analysis of the final APEX Phase 1b clinical results obtained with KSI-101 (Kodiak Sciences Inc.) evaluated to treat macular edema secondary to inflammation (MESI) showed that at week 24 well over ...

A new study published in Clinical & Experimental Ophthalmology found that faricimab was effective in treating patients with neovascular age-related macular degeneration (nAMD) who had not previously ...